95.19
price down icon0.51%   -0.42
after-market Dopo l'orario di chiusura: 95.18 -0.010 -0.01%
loading
Precedente Chiudi:
$95.61
Aprire:
$95.55
Volume 24 ore:
2.57M
Relative Volume:
1.17
Capitalizzazione di mercato:
$18.86B
Reddito:
$8.01B
Utile/perdita netta:
$807.20M
Rapporto P/E:
23.56
EPS:
4.0411
Flusso di cassa netto:
$1.13B
1 W Prestazione:
+7.20%
1M Prestazione:
+4.01%
6M Prestazione:
-6.58%
1 anno Prestazione:
-3.91%
Intervallo 1D:
Value
$94.56
$97.22
Intervallo di 1 settimana:
Value
$87.37
$97.22
Portata 52W:
Value
$84.59
$114.44

Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile

Name
Nome
Zimmer Biomet Holdings Inc
Name
Telefono
(574) 267-6131
Name
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Name
Dipendente
17,000
Name
Cinguettio
@zimmerbiomet
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
ZBH's Discussions on Twitter

Compare ZBH vs ABT, SYK, MDT, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
ZBH
Zimmer Biomet Holdings Inc
95.17 18.95B 8.01B 807.20M 1.13B 4.0411
Medical Devices icon
ABT
Abbott Laboratories
111.46 197.52B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
SYK
Stryker Corp
365.86 139.09B 25.12B 3.25B 4.28B 8.4018
Medical Devices icon
MDT
Medtronic Plc
100.88 129.59B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
BSX
Boston Scientific Corp
74.11 108.96B 20.08B 2.89B 3.82B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
76.45 46.04B 5.88B 1.34B 799.60M 2.3489

Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-09 Downgrade Goldman Neutral → Sell
2026-01-06 Downgrade Raymond James Outperform → Mkt Perform
2026-01-05 Aggiornamento Evercore ISI In-line → Outperform
2025-12-16 Downgrade Robert W. Baird Outperform → Neutral
2025-11-06 Downgrade JP Morgan Overweight → Neutral
2025-09-18 Iniziato Rothschild & Co Redburn Buy
2025-07-15 Aggiornamento Roth Capital Neutral → Buy
2024-12-17 Aggiornamento JP Morgan Neutral → Overweight
2024-09-10 Iniziato Wolfe Research Peer Perform
2024-07-01 Downgrade Piper Sandler Overweight → Neutral
2024-05-30 Iniziato Goldman Neutral
2024-05-21 Aggiornamento Argus Hold → Buy
2024-01-04 Downgrade Evercore ISI Outperform → In-line
2023-10-20 Iniziato ROTH MKM Neutral
2023-08-28 Aggiornamento BTIG Research Neutral → Buy
2023-05-03 Aggiornamento BofA Securities Underperform → Neutral
2023-04-11 Aggiornamento Evercore ISI In-line → Outperform
2023-03-31 Aggiornamento Jefferies Underperform → Hold
2023-03-29 Iniziato UBS Sell
2023-03-10 Aggiornamento Piper Sandler Neutral → Overweight
2023-01-09 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-01-05 Aggiornamento Raymond James Mkt Perform → Outperform
2023-01-03 Downgrade Evercore ISI Outperform → In-line
2022-11-23 Aggiornamento Wells Fargo Underweight → Equal Weight
2022-10-18 Iniziato Barclays Underweight
2022-10-12 Iniziato Jefferies Underperform
2022-05-27 Downgrade Needham Buy → Hold
2022-04-13 Downgrade Truist Buy → Hold
2022-04-01 Downgrade Citigroup Buy → Neutral
2022-03-02 Ripresa BofA Securities Underperform
2022-03-02 Downgrade Loop Capital Buy → Hold
2022-02-08 Downgrade Canaccord Genuity Buy → Hold
2022-02-08 Reiterato Citigroup Buy
2022-02-08 Reiterato Deutsche Bank Hold
2022-02-08 Reiterato JMP Securities Mkt Outperform
2022-02-08 Reiterato JP Morgan Neutral
2022-02-08 Reiterato RBC Capital Mkts Sector Perform
2022-02-08 Reiterato Stifel Buy
2022-02-08 Reiterato Truist Buy
2022-02-08 Reiterato UBS Neutral
2022-02-08 Reiterato Wells Fargo Underweight
2022-02-02 Downgrade UBS Buy → Neutral
2022-01-19 Downgrade Wells Fargo Equal Weight → Underweight
2022-01-10 Downgrade Mizuho Buy → Neutral
2022-01-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-01-04 Downgrade Piper Sandler Overweight → Neutral
2021-12-10 Iniziato RBC Capital Mkts Sector Perform
2021-12-09 Downgrade Needham Strong Buy → Buy
2021-12-07 Iniziato Loop Capital Buy
2021-11-23 Downgrade Argus Buy → Hold
2021-09-14 Ripresa Raymond James Mkt Perform
2021-05-25 Iniziato Barclays Overweight
2021-04-09 Aggiornamento Northland Capital Market Perform → Outperform
2021-01-04 Aggiornamento Evercore ISI In-line → Outperform
2020-12-18 Reiterato Needham Strong Buy
2020-10-20 Iniziato Northland Capital Market Perform
2020-09-11 Iniziato Wolfe Research Outperform
2020-08-05 Reiterato Needham Strong Buy
2020-04-28 Downgrade Guggenheim Buy → Neutral
2020-04-09 Downgrade Evercore ISI Outperform → In-line
2020-04-07 Reiterato Needham Strong Buy
2020-03-05 Iniziato Citigroup Buy
2020-02-13 Iniziato Goldman Buy
2020-01-08 Iniziato SunTrust Buy
2020-01-07 Aggiornamento Piper Jaffray Neutral → Overweight
2020-01-07 Aggiornamento Piper Sandler Neutral → Overweight
2019-12-04 Aggiornamento Raymond James Outperform → Strong Buy
2019-10-07 Aggiornamento BTIG Research Neutral → Buy
2019-09-18 Aggiornamento Canaccord Genuity Hold → Buy
2019-08-12 Aggiornamento Argus Hold → Buy
2019-07-30 Aggiornamento Barclays Underweight → Equal Weight
2019-07-29 Aggiornamento Robert W. Baird Neutral → Outperform
2019-06-11 Aggiornamento Bernstein Underperform → Mkt Perform
2019-04-24 Aggiornamento Needham Buy → Strong Buy
Mostra tutto

Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie

pulisher
10:01 AM

Market Participants Recognise Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings - 富途牛牛

10:01 AM
pulisher
08:44 AM

Skylands Capital LLC Sells 20,100 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

08:44 AM
pulisher
08:26 AM

Sound Shore Management Inc CT Decreases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

08:26 AM
pulisher
07:36 AM

Johnson Investment Counsel Inc. Lowers Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

07:36 AM
pulisher
04:33 AM

Zimmer Biomet Expects Paragon 28 To Power Double Digit Rise In 2026 - Citeline News & Insights

04:33 AM
pulisher
Feb 11, 2026

Zimmer Biomet Holdings Inc (ZBH) Q4 2025 Earnings Call Highlight - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet (NYSE:ZBH) Beats Estimates, Lifts Russell 1000 Healthcare - Kalkine Media

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Citigroup Raises Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Wells Fargo Raises Zimmer Biomet Holdings (ZBH) Price Target to $98 | ZBH Stock News - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Wells Fargo & Company Forecasts Strong Price Appreciation for Zimmer Biomet (NYSE:ZBH) Stock - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

UBS Adjusts Price Target on Zimmer Biomet Holdings to $89 From $86, Maintains Sell Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Rothschild & Co Redburn Adjusts Zimmer Biomet PT to $115 From $125, Maintains Buy Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Barclays Adjusts Zimmer Biomet PT to $100 From $104, Maintains Underweight Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum - Finviz

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2025 earnings call transcript - MSN

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer plans US salesforce reorganization - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet shares climb after fourth-quarter sales and earnings growth - AlphaStreet News

Feb 11, 2026
pulisher
Feb 11, 2026

Zimmer Biomet Q4 Earnings Call Highlights - MarketBeat

Feb 11, 2026
pulisher
Feb 10, 2026

Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid US sales force overhaul and innovation cycle - MSN

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet earnings beat Wall Street expectations - The Journal Gazette

Feb 10, 2026
pulisher
Feb 10, 2026

BTIG Reiterates Buy Rating on Zimmer Biomet (ZBH) with $112 PT | - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (NYSE:ZBH) Earns Hold Rating from Needham & Company LLC - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

BTIG Research Reiterates Buy Rating for Zimmer Biomet (NYSE:ZBH) - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Citigroup Raises Price Target on Zimmer Biomet to $98 From $94, Maintains Neutral Rating - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Wells Fargo Adjusts Price Target on Zimmer Biomet to $98 From $93 - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet beats quarterly estimates on strong implant demand amid US sales overhaul - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet posts Q4 beats, sets 2026 guidance - massdevice.com

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (ZBH) Exceeds Q4 Expectations with Strong Orthoped - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $1,500 million worth of its shares. - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Tranche Update on Zimmer Biomet Holdings, Inc.'s Equity Buyback Plan announced on May 29, 2024. - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations - Finviz

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet Q4 2025 Earnings & 2026 Financial ForecastNews and Statistics - IndexBox

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (NYSE:ZBH) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet beats quarterly estimates on strong hips, knees device demand - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (NYSE:ZBH) Releases FY 2026 Earnings Guidance - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (ZBH) Announces $1.5 Billion Stock Buyback Plan - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (ZBH) Projects Revenue Growth for Fiscal Year 2026 - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (ZBH) Reports Strong Q4 Revenue and Strategic Adva - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer Biomet (ZBH) Q4 Earnings Surpass Expectations, Announces Buyback Plan - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Zimmer: Q4 Earnings Snapshot - kens5.com

Feb 10, 2026
pulisher
Feb 10, 2026

(ZBH) Zimmer Biomet Holdings Expects Full Year 2026 Adjusted EPS Range $8.30$8.45, vs. FactSet Est of $8.46 - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Earnings Flash (ZBH) Zimmer Biomet Holdings, Inc. Reports Q4 Revenue $2.24B, vs. FactSet Est of $2.22B - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Earnings Flash (ZBH) Zimmer Biomet Holdings, Inc. Posts Q4 Adjusted EPS $2.42 per Share, vs. FactSet Est of $1.79 - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

ZIMMER BIOMET HOLDINGS ($ZBH) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 10, 2026

Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices STE
$244.13
price up icon 0.51%
$65.12
price down icon 4.43%
medical_devices PHG
$31.41
price down icon 2.17%
$78.67
price down icon 0.76%
medical_devices EW
$76.45
price down icon 3.69%
Capitalizzazione:     |  Volume (24 ore):